Phase 4 N=242 Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
Migraine
Primary: Overall Satisfaction — 73.7 Scale of 0-100; 100= very satisfied — p=0.0007
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=1,962 RIGHT: Rhythm ID Going Head-to-Head Trial
Tachycardia
Primary: Number of Patients With Inappropriate Ventricular Tachycardia (VT)/Ventricular Fibrillation (VF) Therapy (Shock or Antitachycardia Pacing [ATP]) After the Pre-Discharge…
Phase 4 N=108 Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma
Hilar Cholangiocarcinoma
Primary: Proportion of Patients With Adequate Biliary Drainage in Metallic Stent and Plastic Stent Group.(ITT Analysis) — .7037037; .46296 proportion of participants — p=0.011
Phase 4 N=185 Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children
Hepatitis B
Primary: Number of Subjects With Anti-hepatitis B (Anti-HBs) Antibody Concentration Equal to or Above (≥) 100 Milli-International Units Per Milliliter (mIU/mL) — 88; 84…
Phase 4 N=12 The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure
Hypertension
Primary: Mean Arterial Pressure — 88; 87; 87; 87 mm Hg
Phase 4 N=338 Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease
Pulmonary Disease, Chronic Obstructive
Primary: Mean Change in Exercise Endurance Time (EET) From Baseline (Week 3) to Week 8 — 23.3; 6.0 Seconds (sec) — p=0.181
Phase 4 N=125 Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.
Dermatitis, Chronic
Primary: Number of Participants With Improvement of at Least 2 Grades in the Investigator's Static Global Assessment (ISGA) (Target Hand) Score From Baseline to Day 15 — 26; 18…
Phase 4 N=180 Effects of General Anesthesia and Spinal-Morphine Anesthesia on Recovery and Comfort After Benign Abdominal Hysterectomy
Hysterectomy (MeSH nr: E04.950.300.399)
Primary: Duration of Hospital Stay. — 46; 50 Hours
Phase 4 N=12 Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial
Elderly · Pharmacokinetics · Overactive Bladder
Primary: Cerebral Spinal Fluid Levels of Trospium at Day 10, Hour 5 — NA Picograms per milliliter (pg/mL)
Phase 4 N=111 A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere
Influenza
Primary: Seroconversion — 27; 17; 32; 43 Subjects
Phase 4 N=66 A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms
Anti-biotic Resistance
Primary: Percentage of Subjects With Strain Resistance of the Conjunctiva as Determined by Minimum Inhibitory Concentration (MIC) at Day 14 — 9.4; 0 Percentage of Subjects
Phase 4 N=31 Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory
Attention Deficit Hyperactivity Disorder
Primary: Test of Everyday Attention for Children: Walk, Don't Walk — 13.5; 11 units on a scale — p=<0.01
Phase 4 N=145 Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia
Spasmodic Torticollis
Primary: Dysphagia Incidence Over 10 Weeks — 10; 12 Number of patients
Phase 4 N=209 Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia
Attention Deficit Hyperactivity Disorder · Dyslexia
Primary: Change From Baseline in Attention-Deficit/Hyperactivity Disorder Rating Scale (ADHDRS) Total Score - Parent Version at Week 16 Endpoint — -20.01; -12.27 units on a scale…
Phase 4 N=420 Succinylcholine Versus Rocuronium for Emergency Intubation in Intensive Care
Intubation
Primary: Number of Participants Exhibiting Desaturation >5% — 73; 66 participants